Skip to main content
INDV
NASDAQ Life Sciences

Indivior Beats Q3 Estimates With $1.32 EPS, Revenue Up 13% to $356M

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$35.25
Mkt Cap
$4.161B
52W Low
$24.74
52W High
$42.81
52W Position info
42% above low
Off High info
18% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

INDV sits 42% above its 52-week low of $24.74 on elevated volume (2.1× avg).

Summary

Indivior delivered a clean Q3 beat: adjusted EPS of $1.32 against a $1.12 consensus, and revenue of $356 million versus $329.35 million expected, up 13.4% year over year. Net income came in at $137 million, with reported EPS of $1.12. This follows the 8-K and 10-Q filed earlier today and the August guidance raise to $1.295B–$1.365B, so the quarter confirms the SUBLOCADE-led growth story rather than resetting it. The stock has been weak anyway — down 3.0% this quarter and 3.1% year to date — with attention fixed on the pending all-stock merger of equals with Supernus and the $1 billion special dividend to Indivior holders. Shareholder votes on that deal were set for October 15, 2026.

At the time of this announcement, INDV was trading at $35.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $24.74 to $42.81. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

INDV - Latest Insights

INDV
Nov 02, 2026, 9:27 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $35.56
Real-time Price: $29.51 info
Change: -$6.05 (-17%) info
Market Cap: $6.174B info
INDV
Oct 29, 2026, 8:14 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $36.51
Real-time Price: $29.51 info
Change: -$7.00 (-19%) info
Market Cap: $6.174B info
INDV
Oct 29, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.44
Real-time Price: $29.51 info
Change: -$4.93 (-14%) info
Market Cap: $6.174B info
INDV
Oct 29, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $34.44
Real-time Price: $29.51 info
Change: -$4.93 (-14%) info
Market Cap: $6.174B info
INDV
Oct 06, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.99
Real-time Price: $29.51 info
Change: -$6.48 (-18%) info
Market Cap: $6.174B info